MINNEAPOLIS, MN, February 1, 2022 – Northborne Partners is pleased to announce that it served as the exclusive financial advisor to East Coast Warehouse and Distribution (“ECW”) in connection with the investment received from Equity Group Investments (EGI). EGI is partnering…
MINNEAPOLIS, MN, January 31, 2022 – Northborne Partners is pleased to announce that it served as the exclusive financial advisor to Metro Mold & Design, LLC (“Metro Mold”) on its sale of MMD Medical LLC (“MMD Medical”) to Teamvantage Molding LLC (“Teamvantage”), a portfolio…
MINNEAPOLIS, MN, JANUARY 21, 2022 - Northborne Partners acted as the exclusive financial advisor to Transplant Connect, Inc. (“Transplant Connect”) in connection with an investment received from InVita Healthcare Technologies (“InVita”), a portfolio company of The Riverside…
MINNEAPOLIS, MN, January 14, 2022 – Northborne Partners is pleased to announce that it served as the exclusive financial advisor to Center for Behavioral Health (“CBH”) on its sale to Behavioral Health Group (“BHG”), a portfolio company of The Vistria Group. The transaction…
MINNEAPOLIS, MN (January 4, 2021) – Northborne Partners is excited to announce that it has been nominated for the Tenth Annual BOLD Awards, presented by the Minnesota Chapter of the Association for Corporate Growth® (ACG.) The…
MINNEAPOLIS, MN, December 23, 2021 – Northborne Partners acted as the exclusive financial advisor to Riverwood Group, LLC (“Riverwood”) in its sale to BayMark Health Services (“BayMark”). The transaction closed on December 22, 2021; financial terms were not…
MINNEAPOLIS, MN – December 6, 2021 – Northborne Partners acted as the exclusive financial advisor to Premier Allergist, formerly The Allergy & Asthma Center in its sale to AllerVie Health; financial terms were not disclosed.
Premier Allergist is one of the largest…
PHOENIX, AZ, October 1, 2021 – Northborne Partners acted as the exclusive financial advisor to Verde Industries, Inc. (“Verde”) in its sale to OmniMax International, LLC (“OmniMax”), a portfolio company of SVPGlobal. The transaction closed on September 30, 2021; financial terms…
MINNEAPOLIS, MN, September 23, 2021 – Northborne Partners acted as the exclusive financial advisor to International Biophysics Corporation (“IBC”) in the sale of its AffloVest respiratory therapy business to Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD).…
Premier Boutique Investment Bank Focused on Selling Privately Owned Businesses Continues to Expand
MINNEAPOLIS, MN, August 6, 2021 – Northborne Partners, a leading independent middle-market M&A advisor, has announced several new additions to the Northborne…
Website includes transactions completed by Northborne professionals at prior firms.
Contact us to find out how Northborne can drive value and increase the probability of success of your transaction.
Address
212 3rd Ave N, Suite 500© 2025 Northborne Partners LLC